1. Market Research
  2. > Healthcare Market Trends

Digital PCR and Real-time PCR Market: Forecast until 2022

  • June 2017
  • 218 pages
  • ID: 4973888
In this report:
In 2017, the reagents and consumables segment is expected to account for the largest share of ##.##% of the dPCR market in the U.K. This segment is projected to reach USD ##.## million by 2022 from USD ##.## million in 2017 at a CAGR of ##.##%.
In 2017, the reagents and consumables segment is expected to account for the largest share of ##.##% of the dPCR market in the U.S. This segment is projected to reach USD ##.## million by 2022 from USD ##.## million in 2017 at a CAGR of ##.##%.

Summary

Table of Contents

Search Inside

"The overall digital PCR and real-time market forecasted to grow at a CAGR (Compound annual growth rate) of 8.90 percent."

The overall dPCR and qPCR market is forecasted to grow at a compound annual growth rate (CAGR) of 8.90 percent between 2017 and 2022, to attain ~$5.3B by 2022. The main key factors driving the rise of this market contain increase in the geriatric population, growing incidence of infectious diseases and genetic disorders, growing investments and availability of funds for PCR-based research, and rising use of biomarker profiling for disease diagnosis. Nevertheless, Elements such as high cost of dPCR products and technical limitations combined with qPCR and dPCR are selecting the increase of this market.

"The dPCR technology segment to grow at faster pace than qPCR technology segment during the outlook period."

Established on the type of technology, the dPCR and qPCR market is categorized into digital PCR and quantitative PCR. In 2017, the qPCR technology segment is forecasted to account for the biggest share of the market. On the other hand, the dPCR technology segment is anticipated to increase at the highest CAGR (Compound annual growth rate) during the estimate period. This increase can be accredited to the ongoing technological developments in dPCR, significant adoption of dPCR products among target end users, expansion of distribution networks of emerging dPCR product manufacturers, and increasing private funding for the development and commercialization of innovative dPCR instruments.

"The dPCR instruments segment is anticipated to rise at the highest compound annual growth rate (CAGR) during 2017-2022."

On the basis of product and service, the dPCR and qPCR market is classified into instruments; reagents and consumables; and software and services. The dPCR instruments segment is anticipated to witness the highest increase during the outlook period. The increase of this segment is primarily due to the procedural benefits of dPCR over qPCR, increasing market demand for dPCR procedures (particularly in forensics and drug discovery), and increasing number of dPCR-based researches across the world.

"Asia-Pacific to witness the more important rise during the estimate period (2017-2022)"

North America (NA) is forecasted to hold the biggest share of the overall dPCR and qPCR market in 2017, succeeded by EU. Nevertheless, the Asia-Pacific area is forecast to grow at the quickest rate during the outlook period. Increasing awareness of physicians & healthcare professionals about the benefits of gene-based disease diagnosis and treatment, increasing public-private support to expand novel dPCR and qPCR technologies, solid growth witnessed by the Indian genomics sector, and advancing cancer research in Japan (JP) are the top factors responsible for the rise of this market in the Asia Pacific (APAC) area.

Break of primary members taking part was as mentioned below:

• By Company category - Tier 1 - 45.0 percent, Tier 2 - 34.0 percent and Tier 3 - 21.0 percent

• By Description - D-level - 14.0 percent, C-level - 10.0 percent, Others - 76.0 percent

• By Area - North America continent - 40.0 percent, Europe (EU) - 32.0 percent, APAC - 20.0 percent, RoW - 8.0 percent

Some of the main market actors in the dPCR and qPCR market are Thermo Fisher Scientific (NYSE:TMO), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Qiagen NV (NASDAQ:QGEN), Takara Bio, Incorporated, Agilent Technologies Inc., bioMérieux S.A., Fluidigm Corporation, Danaher (NYSE:DHR), and Abbott Laboratories (NYSE:ABT), among others.

Segment Research

This report studies the dPCR and qPCR market established on technology, product and service, application, final user, and area. The study also studies factors (including drivers, industry restraints, alternatives, and opportunities) which affect the market increase in a positive and negative manner. It examines possibilities and opportunities in the sector for partners and offers details of the competitive landscape for industry top players.

The analysis forecasts the revenue of the market segments with respect to four main regions, that is, North America (NA), EU, Asia-Pac, and the Rest of the globe. The dPCR and qPCR market report profiles main actors who are involved in the manufacturing and commercialization of dPCR and qPCR products and analyzes their core competencies. The report tracks and analyzes competitive developments including new product launches and enhancements; mergers and acquisition; alliances, collaborations and strategic agreements; and business developments in the dPCR and qPCR market.

Why Purchasing This Study Can Help You:

From an insight prospect, this market research highlights on several levels of review of the top actors and company descriptions, which together comprise and examine basic views on the competitive landscape; coming out and high-growth segments of the dPCR and qPCR market; and high-growth areas and their respective drivers, market restraints, opportunities, and alternatives.

The market research will increase both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate organizations in garnering a greater market share. Companies obtaining the industry report could use any one or an aggregation of the below-mentioned five strategies (business entry, product improvement/innovative projects, industry development, industry diversification, and opposing assessment) for strengthening their market shares.

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on the most important 10 market actors in the dPCR and qPCR market. The analysis examines the Digital PCR and qPCR market by technology, product and service, application, end-user, and area

• Product Development/Innovative products: In-depth understanding on analysis and growth activities, developmental pipeline, and recent product launches in the dPCR and qPCR market

• Market Development: Highlighted information about the profitable emerging sectors. The market research examines the industries for different dPCR and qPCR products across four geographies (North America continent, Europe (EU), Asia Pacific (APAC), and the Rest of the globe)

• opposing assessment: Assessment of market shares, strategies, distribution networks, and manufacturing competences of the key players in the dPCR and qPCR market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

3D Cell Culture Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Global 3D cell culture market projected to grow at a CAGR of 20.3%”The 3D cell culture market is expected to reach USD 1,702.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3%. The ...

Life Science Instrumentation Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • September 2017
  • by MarketsandMarkets

“Life science instrumentation market projected to grow at a CAGR of 6.7%”The global life science instrumentation market is expected to reach USD 75.24 billion by 2022 from USD 54.49 million in 2017, ...

Patient Derived Xenograft/PDX Models Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • September 2017
  • by MarketsandMarkets

“PDX models market is projected to grow at a CAGR of 16.7%”The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.